- Home
- PGNY vs AGIO Comparison
PGNY vs AGIO Comparison
Compare PGNY & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGNY
- AGIO
- Stock Information
- Founded
- PGNY 2008
- AGIO 2007
- Country
- PGNY United States
- AGIO United States
- Employees
- PGNY N/A
- AGIO N/A
- Industry
- PGNY Misc Health and Biotechnology Services
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- PGNY Health Care
- AGIO Health Care
- Exchange
- PGNY Nasdaq
- AGIO Nasdaq
- Market Cap
- PGNY 1.5B
- AGIO 2.4B
- IPO Year
- PGNY 2019
- AGIO 2013
- Fundamental
- Price
- PGNY $16.68
- AGIO $44.14
- Analyst Decision
- PGNY Buy
- AGIO Buy
- Analyst Count
- PGNY 9
- AGIO 7
- Target Price
- PGNY $22.67
- AGIO $52.00
- AVG Volume (30 Days)
- PGNY 2.9M
- AGIO 654.8K
- Earning Date
- PGNY 11-05-2024
- AGIO 10-31-2024
- Dividend Yield
- PGNY N/A
- AGIO N/A
- EPS Growth
- PGNY 28.49
- AGIO N/A
- EPS
- PGNY 0.63
- AGIO N/A
- Revenue
- PGNY $1,132,996,000.00
- AGIO $31,306,000.00
- Revenue This Year
- PGNY $9.77
- AGIO $44.80
- Revenue Next Year
- PGNY $2.51
- AGIO $174.95
- P/E Ratio
- PGNY $26.49
- AGIO N/A
- Revenue Growth
- PGNY 18.33
- AGIO 55.39
- 52 Week Low
- PGNY $13.93
- AGIO $19.80
- 52 Week High
- PGNY $42.08
- AGIO $53.29
- Technical
- Relative Strength Index (RSI)
- PGNY 39.54
- AGIO 52.72
- Support Level
- PGNY $15.46
- AGIO $40.94
- Resistance Level
- PGNY $16.66
- AGIO $42.78
- Average True Range (ATR)
- PGNY 0.57
- AGIO 1.56
- MACD
- PGNY 0.25
- AGIO 0.19
- Stochastic Oscillator
- PGNY 75.31
- AGIO 66.67
About PGNY Progyny Inc.
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.